Rina Rosin-Arbesfeld, PhD

Most cancer cells have undergone changes in one or more of the pathways that signal cells to limit proliferation. When altered, the Wnt signaling pathway is implicated in the development of various cancers, including solid tumors and some blood cancers. Dr. Rosin-Arbesfeld and her team are working to better understand how the Wnt pathway functions in the bloodstream. This knowledge will shed light on how blood cancers like leukemia and lymphoma develop, and should, ultimately lead to new Wnt-targeted therapies. 

View Grant Recipient Profile